pharmaceutical innovation

Roche and NVIDIA expand AI infrastructure with 2,176 on-premises GPUs across U.S. and Europe, totaling 3,500 Blackwell units to accelerate drug discovery and diagnostics.

NASA awards Redwire $4 million for drug development in cancer, osteoporosis, and obesity. Shares rise 0.98% following funding announcement.

Global antibiotics market to grow from USD 55.60B in 2025 to USD 70.64B by 2031 at 4.07% CAGR, driven by antimicrobial resistance and innovation.

EMA approves DNDi-Sanofi's Acoziborole Winthrop, a simplified single-dose sleeping sickness treatment with 96% efficacy. Sanofi will donate it to WHO for endemic countries.

Eton Pharma gains FDA approval for DESMODA, the first liquid desmopressin formulation for central diabetes insipidus, launching March 9 with projected peak sales of $30-50 million.

J&J stock hits record highs with 14% monthly returns, outperforming tech due to stable dividends, strong cash flow, and lower volatility amid market uncertainty.

Vertex Pharmaceuticals expands beyond cystic fibrosis dominance into gene-editing treatments for blood disorders and pain management, targeting $13.1B revenue with non-CF products generating $500M+.